These outcomes, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the notion of focusing on ACKR3 as a novel technique to modulate the opioid system, which could open up new therapeutic avenues for opioid-related disorders. In reaction to this https://meistery369uyl5.mybuzzblog.com/profile